Literature DB >> 23918624

Second harmonic microscopic imaging and spectroscopic characterization in prostate pathological tissue.

Yanyue Huang1, Zhengfei Zhuang.   

Abstract

Second harmonic microscopic imaging and spectroscopy technology has become a powerful tool for biomedical studies, especially in cancer research. In this paper, second harmonic generation in benign prostatic hyperplasia (BPH) and prostate cancer (PC) tissues in mouse model (C57BL6) have been reported. Excitated samples with different wavelength near-infrared laser from 780 to 850 nm we found that second harmonic signals from BPH nuclei stronger than that from PC, and a wavelength sensitivity was also observed in this experiment. Providing useful help for prostate malignancy diagnosis and identifying tissue components on clinic.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  prostate cancer; prostatic hyperplasia; second harmonic generation; wavelength sensitivity

Mesh:

Year:  2013        PMID: 23918624     DOI: 10.1002/sca.21116

Source DB:  PubMed          Journal:  Scanning        ISSN: 0161-0457            Impact factor:   1.932


  3 in total

1.  Collagen organization of renal cell carcinoma differs between low and high grade tumors.

Authors:  Sara L Best; Yuming Liu; Adib Keikhosravi; Cole R Drifka; Kaitlin M Woo; Guneet S Mehta; Marie Altwegg; Terra N Thimm; Matthew Houlihan; Jeremy S Bredfeldt; E Jason Abel; Wei Huang; Kevin W Eliceiri
Journal:  BMC Cancer       Date:  2019-05-23       Impact factor: 4.430

2.  Non-disruptive collagen characterization in clinical histopathology using cross-modality image synthesis.

Authors:  Adib Keikhosravi; Bin Li; Yuming Liu; Matthew W Conklin; Agnes G Loeffler; Kevin W Eliceiri
Journal:  Commun Biol       Date:  2020-07-31

3.  Real-time polarization microscopy of fibrillar collagen in histopathology.

Authors:  Adib Keikhosravi; Michael Shribak; Matthew W Conklin; Yuming Liu; Bin Li; Agnes Loeffler; Richard M Levenson; Kevin W Eliceiri
Journal:  Sci Rep       Date:  2021-09-24       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.